Skip to content Skip to footer
Stocks rally on new vaccine hopes

Stocks rally on new vaccine hopes – 16th November

Similar to last week, markets opened this Monday with the news that a COVID-19 vaccine was over 90% effective in treating the virus.

The news from Moderna said that data showed its coronavirus vaccine was more than 94.5% effective in preventing COVID-19. This saw markets around the globe rally, however at a slower pace than last week’s announcement from Pfizer.

In the United States, the benchmark S&P 500 index was up by 0.81% as of writing, whilst the Nikkei 225 in Japan climbed by over 2% to reach its highest level in 29 years.

Deadline for Brexit deal edges closer

With the Brexit deadline looming, many have labelled this a pivotal week for both parties, if a “no-deal” scenario is to be avoided.

The December deadline is 6 weeks away, however British and European Union negotiators continue to differ on several areas of the proposed deal. In a statement reading talks, a EU official stated that, “It’s getting terribly late and may be too late already (to strike a deal)”.

However Ireland, which is at the centre of the dispute, stated via its Foreign Minister that, “We are more likely to get a deal than not, purely because the consequences of not getting a deal are so significant and so costly for the UK and Ireland as it happens, and for some other EU countries”.

Markets now wait to see how the story progresses.

FTSE 100 hits 5-month high

The FTSE 100 reached a 5-month high today, despite the news that Prime Minister Boris Johnson was self-isolating after coming into contact with a person infected with COVID-19.

In a tweet confirming the situation, the PM stated that, “Hi folks, I’ve been instructed by our NHS Test & Trace scheme to self-isolate for two weeks, after being in contact with someone with Covid-19.

I’m in good health and have no symptoms, and will continue to lead on our response to the virus & our plans to #BuildBackBetter”

The FTSE was up 1.66%.

Quote of the day – It’s not whether you’re right or wrong that’s important, it’s how much money you make when you’re right and how much you lose when you’re wrong.”

George Soros

To stay up to date with the markets we encourage traders to view our Trade Gate Hub for more real time insights into Crude, Gold and many other markets.

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.
Website: www.tradeviewforex.com

Tradeview Asia Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.
Website: www.tvmgloballtd.com

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.
Website: www.tradeview.eu

Tradeview Financial Markets S.A.C Global

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.
Website: www.tradeviewlatam.com